HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
26 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
PLAT
plasminogen activator, tissue type
Chromosome 8 · 8p11.21
NCBI Gene: 5327Ensembl: ENSG00000104368.19HGNC: HGNC:9051UniProt: B4DN26
391PubMed Papers
20Diseases
8Drugs
0Pathogenic Variants
FUNCTIONAL ROLE
Protease
RESEARCH IMPACT
Highly StudiedTrending
CLINICAL
FDA Approved Target
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
plasminogen activationnegative regulation of proteolysissignaling receptor bindingprotein bindingstrokemyocardial infarctionpulmonary embolismhemorrhage
✦AI Summary

PLAT encodes tissue plasminogen activator (tPA), a serine protease that converts inactive plasminogen to active plasmin by cleaving a single Arg-Val bond, playing crucial roles in fibrinolysis and tissue remodeling 1. Beyond its classical thrombolytic function, PLAT exhibits diverse physiological roles including neuroprotection through modulation of autophagy pathways. Following cerebral ischemia, PLAT treatment decreases deleterious neuronal autophagy by degrading IGFBP3, increasing IGF1 bioavailability, and activating IGF1R-mediated PI3K-AKT-MTOR signaling 1. In vascular biology, PLAT-expressing pulmonary capillary cells (Plat+ Capillary-1) play critical roles in innate immune responses during sepsis-induced acute lung injury, facilitating granulocyte adherence to capillaries via ICAM-1 interactions 2. In oncology, PLAT participates in tumor-endothelial cell communication through the PLG-PLAT signaling axis, where FABP1+ renal cell carcinoma cells promote angiogenesis by triggering this pathway 3. Clinically, recombinant PLAT is used for thrombolytic therapy in stroke and other thrombotic conditions, with TCD monitoring proving effective for assessing treatment response 4. The multifaceted functions of PLAT extend beyond hemostasis to include tissue remodeling, neuroprotection, immune responses, and pathological angiogenesis.

Sources cited
1
PLAT converts plasminogen to plasmin, decreases deleterious autophagy via IGF1R-PI3K-AKT-MTOR signaling, and degrades IGFBP3 to increase IGF1 bioavailability
PMID: 34520334
2
Plat+ capillary cells mediate granulocyte adherence during sepsis-induced acute lung injury through ICAM-1 interactions
PMID: 38348045
3
PLAT participates in PLG-PLAT signaling axis between tumor cells and endothelial cells to promote angiogenesis
PMID: 40518526
4
TCD monitoring can assess treatment efficacy of intravenous tissue plasminogen activator
PMID: 31761060
⚠Limited data available — This gene has 4 indexed publications. Summary and analysis may be incomplete.
Disease Associationsⓘ20
strokeOpen Targets
0.60Moderate
myocardial infarctionOpen Targets
0.60Moderate
pulmonary embolismOpen Targets
0.59Moderate
hemorrhageOpen Targets
0.58Moderate
Recurrent thrombophlebitisOpen Targets
0.50Moderate
acute myocardial infarctionOpen Targets
0.49Moderate
ST Elevation Myocardial InfarctionOpen Targets
0.47Moderate
heart failureOpen Targets
0.47Moderate
Ischemic strokeOpen Targets
0.44Moderate
congestive heart failureOpen Targets
0.37Weak
hemorrhagic diseaseOpen Targets
0.37Weak
eye diseaseOpen Targets
0.37Weak
retinal artery occlusionOpen Targets
0.35Weak
Abruptio PlacentaeOpen Targets
0.35Weak
acute respiratory distress syndromeOpen Targets
0.33Weak
preeclampsiaOpen Targets
0.33Weak
memory impairmentOpen Targets
0.32Weak
abscessOpen Targets
0.31Weak
intracerebral hemorrhageOpen Targets
0.30Weak
subarachnoid hemorrhageOpen Targets
0.29Weak
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Drug Targets8
ALTEPLASEApproved
Tissue-type plasminogen activator exogenous protein
Recurrent thrombophlebitis
AMINOCAPROIC ACIDApproved
Plasminogen inhibitor
hemorrhage
DUTEPLASEApproved
Tissue-type plasminogen activator exogenous protein
LANOTEPLASEPREAPPROVAL
Tissue-type plasminogen activator exogenous protein
myocardial infarction
MONTEPLASEApproved
Tissue-type plasminogen activator exogenous protein
PAMITEPLASEApproved
Tissue-type plasminogen activator exogenous protein
RETEPLASEApproved
Tissue-type plasminogen activator exogenous protein
Recurrent thrombophlebitis
TENECTEPLASEApproved
Tissue-type plasminogen activator exogenous protein
acute myocardial infarction
Related Genes
ANXA2Protein interaction100%SERPINB2Protein interaction99%S100A10Protein interaction99%LRP1Protein interaction99%IL6Protein interaction97%VWFProtein interaction93%
Tissue Expression6 tissues
Heart
100%
Lung
98%
Ovary
77%
Brain
32%
Liver
25%
Bone Marrow
4%
Gene Interaction Network
Click a node to explore
PLATANXA2SERPINB2S100A10LRP1IL6VWF
PROTEIN STRUCTURE
Preparing viewer…
PDB1RTF · 2.30 Å · X-ray
View on RCSB ↗
Constraintⓘ
LOEUFⓘ
0.80LoF Tolerant
pLIⓘ
0.00Tolerant
Observed/Expected LoF0.60 [0.46–0.80]
RankingsWhere PLAT stands among ~20K protein-coding genes
  • #757of 20,598
    Most Researched391 · top 5%
  • #207of 1,025
    FDA-Approved Drug Targets7 · top quartile
  • #6,701of 17,882
    Most Constrained (LOEUF)0.80
Genes detectedPLAT
Sources retrieved26 papers
Response time—
📄 Sources
26▼
1
Single-cell multi-omics reveals that FABP1 + renal cell carcinoma drive tumor angiogenesis through the PLG-PLAT axis under fatty acid reprogramming.
PMID: 40518526
Mol Cancer · 2025
1.00
2
Lung single-cell RNA profiling reveals response of pulmonary capillary to sepsis-induced acute lung injury.
PMID: 38348045
Front Immunol · 2024
0.90
3
Neuro-ultrasonography.
PMID: 31761060
Neurol Clin · 2020
0.80
4
Plat-E: an efficient and stable system for transient packaging of retroviruses.
PMID: 10871756
Gene Ther · 2000
0.70
5
CHI3L1 on fibrinolytic system imbalance in chronic rhinosinusitis with nasal polyp.
PMID: 38975344
Front Immunol · 2024
0.68